{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-051292","form_type":"8-K","ticker":"DRIO","cik":"0001533998","company_name":"DarioHealth Corp.","filed_at":"2025-05-21T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.661939+00:00","generated_at":"2026-05-20T22:28:25.719033+00:00","sec_items":["5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"DarioHealth extends mandatory conversion period for Series C preferred stock from 15 to 24 months","bullets":["Mandatory conversion period extended from 15 to 24 months for Series C, C-1, C-2 preferred stock.","Preferred holders will receive a quarterly dividend of 15% of common shares issuable upon conversion.","No new securities were issued or sold as a result of the amendment.","Amended and restated certificates of designation filed on May 20, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-051292","json":"https://secwatch.observer/filing/0001104659-25-051292.json","markdown":"https://secwatch.observer/filing/0001104659-25-051292.md","text":"https://secwatch.observer/filing/0001104659-25-051292.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1533998/000110465925051292/0001104659-25-051292-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1533998/000110465925051292/tm2515738d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T22:28:25.719033+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"56710865c53e64f8e9b0284d3b699df012428ec1","claim":"DarioHealth Corp.: Amended the Series C, C-1, and C-2 Certificates of Designation to extend the mandatory conversion period from 15 to 24 months and add a quarterly dividend of 15% of Common Stock issuable upon conversion (effective 2025-05-20).","evidence_excerpt":"On May 20, 2025, DarioHealth Corp. (the “Company”), upon obtaining the vote of a majority of the holders of the relevant classes of preferred stock, filed an Amended and Restated Certificate of Designation of Preferences, Rights and Limitations of the Company’s Series C Preferred Stock","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1533998/000110465925051292/0001104659-25-051292-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-05-20"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}